An inter-residue network model to identify mutational-constrained regions on the Ebola coat glycoprotein

[1]  U. Baxa,et al.  Structural and molecular basis for Ebola virus neutralization by protective human antibodies , 2016, Science.

[2]  J. Mascola,et al.  Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody , 2016, Science.

[3]  G. Gao,et al.  Two-mAb cocktail protects macaques against the Makona variant of Ebola virus , 2016, Science Translational Medicine.

[4]  D. Burton,et al.  Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak , 2016, Science.

[5]  Jonathan R. Lai,et al.  Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses , 2015, Journal of Virology.

[6]  J. Dye,et al.  Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein , 2015, Journal of Virology.

[7]  V. Volchkov,et al.  Characterization of a Novel Neutralizing Monoclonal Antibody Against Ebola Virus GP. , 2015, The Journal of infectious diseases.

[8]  John-Arne Røttingen,et al.  Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial , 2015, The Lancet.

[9]  J. Rucker,et al.  Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies , 2015, Journal of Virology.

[10]  K. C. Zoon,et al.  Mutation rate and genotype variation of Ebola virus from Mali case sequences , 2015, Science.

[11]  X. Qiu,et al.  The multiple roles of sGP in Ebola pathogenesis. , 2015, Viral immunology.

[12]  W. Dowling,et al.  Focus on Ebola virus research. , 2015, Viral immunology.

[13]  J. Strong,et al.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™ , 2014, Nature.

[14]  Joshua C. Johnson,et al.  Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail , 2013, Science Translational Medicine.

[15]  X. Qiu,et al.  Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies , 2012, Science Translational Medicine.

[16]  K. Chandran,et al.  Filovirus entry into cells - new insights. , 2012, Current opinion in virology.

[17]  I. Wilson,et al.  Networks link antigenic and receptor-binding sites of influenza hemagglutinin: Mechanistic insight into fitter strain propagation , 2011, Scientific reports.

[18]  G. Nabel,et al.  Biochemical and Structural Characterization of Cathepsin L-Processed Ebola Virus Glycoprotein: Implications for Viral Entry and Immunogenicity , 2010, Journal of Virology.

[19]  D. Burton,et al.  Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor , 2008, Nature.

[20]  Ghislain Moussavou,et al.  The natural history of Ebola virus in Africa. , 2005, Microbes and infection.

[21]  A. Sanchez,et al.  The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. , 1996, Proceedings of the National Academy of Sciences of the United States of America.